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Abstract
Background: In large-scale epidemiology, bloodspot sampling by fingerstick onto filter paper has many advantages,
including ease and low costs of collection, processing and transport. We describe the development of an enzyme-linked
immunoassay (ELISA) for quantifying insulin from dried blood spots and demonstrate its application in a large trial.
Methods: We adapted an existing commercial kit (Mercodia Human Insulin ELISA, 10-1113-01) to quantify insulin from two 3-
mm diameter discs (<6 mL of blood) punched from whole blood standards and from trial samples. Paediatricians collected
dried blood spots in a follow-up of 13,879 fasted children aged 11.5 years (interquartile range 11.3–11.8 years) from 31 trial
sites across Belarus. We quantified bloodspot insulin levels and examined their distribution by demography and
anthropometry.
Results: Mean intra-assay (n=157) coefficients of variation were 15% and 6% for ‘low’ (6.7 mU/L) and ‘high’ (23.1 mU/L)
values, respectively; the respective inter-assay values (n=33) were 23% and 11%. The intraclass correlation coefficient
between 50 paired whole bloodspot versus serum samples, collected simultaneously, was 0.90 (95% confidence interval
0.85 to 0.95). Bloodspot insulin was stable for at least 31 months at 280uC, for one week at +30uC and following four freeze-
thaw cycles. Paediatricians collected a median of 8 blood spots from 13,487 (97%) children. The geometric mean insulin (log
standard deviation) concentrations amongst 12,812 children were 3.0 mU/L (1.1) in boys and 4.0 mU/L (1.0) in girls and
were positively associated with pubertal stage, measures of central and peripheral adiposity, height and fasting glucose.
Conclusions: Our simple and convenient bloodspot assay is suitable for the measurement of insulin in very small volumes of
blood collected on filter paper cards and can be applied to large-scale epidemiology studies of the early-life determinants of
circulating insulin.
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Introduction
Raised insulin levels in children are a marker for insulin
resistance, [1,2] elevated cardiovascular disease risk factors[3–6]
and early atherosclerosis. [7] Furthermore, high insulin levels in
childhood track into adulthood, [8,9] when they are associated
with type 2 diabetes,[10–12] cardiovascular disease[13–16] and
premature mortality. [16,17] There is, therefore, substantial
interest in large-scale epidemiology studies of the genetic and
environmental determinants of insulin levels in childhood[18–27]
to inform strategies for the prevention of insulin resistance and its
sequelae. [28].
Important challenges in large-scale epidemiology include non-
acceptance of venepuncture by children and/or their parents; the
costs, safety and logistics of serum or plasma separation by
centrifugation; and frozen storage and transport of aliquots. An
PLOS ONE | www.plosone.org 1 October 2012 | Volume 7 | Issue 10 | e46752alternative procedure involves capillary puncture of the finger pulp
to collect bloodspots which are then dried on filter paper. [29,30]
The major advantages of dried blood spot sampling are minimal
training, lower cost than venepuncture, acceptability to parents
and children, [30] negligible processing requirements (cards must
be air dried), low biohazard risk because samples cannot leak and
the ease of storage and transport of filter paper cards. [29,31].
The use of dried blood spots is currently limited to large-scale
paediatric screening programs for rare inherited disorders. There
is, however, interest in developing and validating a wide range of
bloodspot assays, and developments include radioimmunoassay
[32] and chemiluminescence [33] methods for insulin quantifica-
tion in dried blood spots. Radioimmunoassays require regulatory
compliance, because of the use of radioisotopes, and both
radioimmunoassay and chemiluminescence methods require
specialised and costly equipment (radiation-counting apparatus
or a luminometer, respectively) that may not be present in many
laboratories. We are not aware of any reports using enzyme-linked
immunoassay (ELISA), which offers the important advantage that
results can be read on universally available microtitre plate
readers, without the need for regulatory approvals to use
radioisotopes or more specialised and costly measuring equipment.
Development and validation of an ELISA blood spot assay offers a
simple, convenient and novel alternative method of measuring
insulin in large-scale epidemiology studies in a wide range of
settings.
We describe the development and validation of an ELISA for
quantification of insulin from dried blood spots using a simple
adaptation of an existing commercial kit originally designed for use
on serum or plasma (Mercodia Human Insulin ELISA, catalogue number:
10-1113-01, Mercodia AB, Sweden). The kit quantifies insulin using a
solid phase, two-site enzyme immunoassay, based on the direct
sandwich technique in which two monoclonal antibodies are
directed against separate antigenic determinants on the insulin
molecule. We show the successful practical application of our dried
blood spot assay in a large-scale, multicentre trial (the Promotion
of Breastfeeding Intervention Trial, PROBIT [34]) by describing
the distribution and correlates of fasting insulin levels measured on
over 12,000 children aged 11.5 years from 31 polyclinics
distributed across the Republic of Belarus.
Materials and Methods
Materials
Blood samples were collected onto Food and Drug Adminis-
tration approved Whatman 903 filter paper cards, [35] pre-printed
with eight 10 mm diameter circles, standardized to absorb blood
in a homogeneous manner so that uniform punches from any
section of the sample yield the same quantity of blood. [36] The
Human Insulin ELISA kit was from Mercodia AB, Sweden, which
has no detectable cross-reactivity against c-peptide or proinsulin
(both ,0.01%) and showed excellent agreement against an isotope
dilution–liquid chromatography/tandem mass spectrometry
(IDMS) measurement procedure calibrated using purified recom-
binant insulin. [37] This kit was modified by Mercodia,i n
collaboration with the PROBIT study investigators, to produce a
Mercodia Blood Spot Insulin ELISA kit, using the same antibodies
as in the Human Insulin ELISA kit (catalogue number: 10-1113-01).
Instruments used included an automatic filter paper card puncher
(Wallac DBS (Dried Blood Spot) Puncher, product number: 1296-
071, Perkin Elmer, USA), a microplate washing device (DELFIA
Washer-Diskremove, product number: 1296-0010 Perkin Elmer,
USA), a plate shaker (DELFIA Plateshaker, product num-
ber:1296-003, Perkin Elmer, USA) and a microplate reader
(VICTOR3 Multilabel Reader, product number: 1420-012,
Perkin Elmer, USA) with a 450 nm filter.
Preparation of Bloodspot Insulin Standards and Internal
Quality Control Samples
To minimize matrix differences and maximize comparability
between the standards, quality control samples and the trial
samples, whole blood insulin standards (diluted to 1, 3, 10, 30 and
50 mU/L whole blood) and internal quality control samples were
prepared by Mercodia using recombinant human insulin in insulin
ELISA calibrator buffer, article number 20-2615, mixed with
washed red blood cells (in proportions 60:40 for a 0.40
haematocrit), followed by application to Whatman 903 filter
paper. Standards were calibrated against the Human Insulin
ELISA kit, in turn calibrated against the 1st International
Reference Preparation 66/304. The detection limit (1mU/L) in
dried blood spots was determined using the methodology
described in ISO11843-part 4. [38].
Assay Procedure
All frozen blood spot cards (see sample collection below) were
brought to room temperature before being removed from the
plastic bags for assaying. Two 3-mm discs (< 6 mL of blood)
were punched from the blood spots (of the standards, quality
control samples and the trial samples) using an automatic
puncher into 96-well microtitre plates, precoated with mouse
anti-human insulin monoclonals. Two 3-mm discs were used in
each assay well to ensure an adequate sample volume and
elution from the bloodspots. Insulin was extracted from the discs
by incubation for at least 16 hours in a refrigerator with 100 mL
peroxidase conjugated mouse monoclonal anti-insulin diluted
with Mercodia enzyme conjugate buffer, article number 20-
2627. Following incubation, the contents of the wells were
discarded, any remaining filter paper discs carefully removed
and the plates washed 6 times with 350 mL of wash solution
(Tris-buffered saline) to remove unbound enzyme labelled
antibody. The bound conjugate was detected by a 30 minute
incubation with 200 mL of 3,39,5,59-tetramethylbenzidine (TMB)
added to each well before adding 50 mL of stop solution of
0.5 mol/L of H2SO4 to terminate the peroxidase/TMB reaction
and give a colorimetric endpoint that was read spectrophoto-
metrically at 450 nm. The run-specific absorbance of the
standards was plotted against the assigned concentration in
mU/L of the whole blood filter paper standard values (omitting
calibrator 0) using the log scale on both x and y axes. The
concentration of the samples was read from the smoothed cubic
spline fitted standard curve. Samples with insulin levels above
the highest standard (50 mU/L) were reanalyzed by using only
one 3-mm disc instead of two (effectively diluting 1 in 2) and
the results multiplied by 2.
Inter- and Intra-assay Imprecision
Inter- and intra-assay imprecision was assessed using internal
quality control samples at two levels: low (6.7 mU/L) and high
(23.1 mU/L). Intra-assay imprecision for low and high concen-
trations of insulin was established from duplicate analysis
(n=157). The inter-assay imprecision was determined from 33
separate runs over a period of 15 months. Both intra- and inter-
assay imprecision include between-spot extraction variations.
Stability
Stability studies were conducted at both the Mercodia laboratory
and the central analytical laboratory for the PROBIT trial based
Blood Spot Enzyme Linked Immunoassay for Insulin
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16 sets of bloodspot insulin standards were stored at 280uC for up
to 2 months and exposed to up to four freeze–thaw cycles. Mercodia
also assessed the stability of the samples when stressed at +30uC for
one hour, 24 hours, 48 hours and one week. To assess stability at
280uC over the longer term, 3 sets of whole blood samples in
Minsk were spotted onto Whatman 903 cards, cut into strips
containing one blood spot per strip, and frozen at 280uC. Prior to
freezing, baseline (pre-storage) values were established using 30
replicates of each fresh blood spot sample. Approximately
monthly, for a period of 26 months, a different strip was thawed
(to ensure insulin levels were based on only one thaw) and the
insulin value measured. We also stored low (6.7 mU/L) and high
(23.1 mU/L) internal quality control samples, prepared on the
same occasion in the same batch by Mercodia, at 280uC and
repeated the assay at regular intervals, after between 7 and 31
months of frozen storage (the IQCs were stored for longer than the
Minsk samples).
Comparison between Sera and Dried Blood Spots
We compared fasting insulin concentrations in serum (measured
using Mercodia’s Human Insulin ELISA) with insulin concentra-
tions measured from dried blood spots, collected simultaneously
from 50 children in Minsk. Whole blood samples were allowed to
stand at room temperature for 2–4 hours then centrifuged at
3000 rpm for 5 minutes before separating the serum. Blood spots
Figure 1. Typical calibration curve. Whole bloodspot insulin standards at 0, 1, 3, 10, 30 and 50 mU/L (log-log scale).
doi:10.1371/journal.pone.0046752.g001
Table 1. Intra- and inter-assay imprecision of dried whole bloodspot insulin assays.
Sample Mean insulin (mU/L)
Mean standard deviation of repeated
measures Coefficient of variation
Intra-assay (n=157)
1 6.7 1.02 15%
2 23.1 1.35 6%
Inter-assay (n=33)
1 6.7 1.55 23%
2 23.1 2.57 11%
doi:10.1371/journal.pone.0046752.t001
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PLOS ONE | www.plosone.org 3 October 2012 | Volume 7 | Issue 10 | e46752Figure 2. Stability of insulin concentrations measured from dried blood spots at 2806C for 8 weeks. Comparison of fasting insulin
values for dried blood spot samples stored at 280uC for 8 weeks versus fasting insulin concentrations measured from dried blood spots prior to
storage.
doi:10.1371/journal.pone.0046752.g002
Figure 3. Bland-Altman plot for insulin values from fresh minus frozen samples. The difference in fasted bloodspot insulin from fresh
sample minus the same sample frozen for 8 weeks at 280uC.
doi:10.1371/journal.pone.0046752.g003
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PLOS ONE | www.plosone.org 4 October 2012 | Volume 7 | Issue 10 | e46752Figure 4. Stability of insulin concentrations measured from dried blood spots at +306C for 1 weeks. Bloodspot fasting insulin
concentrations from three samples analysed at baseline (time=0), and after 1 hour, 12 hours, 24 hours, 48 hours and 1 week at +30uC.
doi:10.1371/journal.pone.0046752.g004
Figure 5. Stability of fasting insulin stored at 280uC for 26 months. Fasting insulin concentrations of three bloodspot samples analysed prior
to freezing (time 0) and then at regular intervals over 26 months. For sample 1, the middle red line is the insulin concentration at time 0 and the
upper and lower red lines are the 95% reference range (calculated from the standard deviation of 30 replicates of the time 0 value). For samples 2 and
3, the lines are coloured green and blue, respectively.
doi:10.1371/journal.pone.0046752.g005
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before assaying.
Distribution of Insulin by Demographic and Clinical
Characteristics
We followed up 13,879 children aged 11.5 years (interquartile
range 11.3–11.8 years) who were participants in a multicentre trial
of a breastfeeding promotion intervention involving 31 polyclinics
(39 paediatricians) located throughout the Republic of Belarus.
[34] Children who were eligible for the trial (healthy, term
newborns whose mother initiated breastfeeding) were originally
recruited at birth between 1996 and 1997, [34] and have been
followed up intermittently since then, including the 11.5 year
follow-up reported here between 2008–2010. At 11.5 years, dried
blood spots were collected from the children as described below.
The children also had whole blood fasting glucose measured by
glucometer (Roche ACCU-CHEK Advantage meter system, F.
Hoffmann-La Roche AG, Basel, Switzerland) and the following
physical measurements (amongst others not reported here) were
made by study paediatricians: Tanner pubertal stage, height,
weight, body mass index (BMI, weight (kg)/height (m)
2), skinfold
thicknesses, waist circumference and leg-to-leg bioimpedence
(Tanita TBF 300GS, Tanita Europe BV, Netherlands) for
calculation of fat-mass. Birthweight had been collected when the
children were recruited into the trial at birth in 1996/1997. [34].
Sample Collection
Children participating in the PROBIT trial follow-up were
asked to fast for at least 8 hours. Up to 8 drops of fingertip
capillary blood were obtained by paediatricians and applied to the
pre-printed circles to form one discrete spot per drop, following
specific guidelines [35,39] and training (see below). The finger-
prick was made using a sterile, single-use disposable lancet device
with three depth settings designed to minimize pain (Roche
ACCU-CHEK Safe-T-Pro Plus lancet, Roche Diagnostics Corp.,
Indianapolis, USA). To avoid contact of the fresh blood filter-
paper sample with potential contaminants, the sample was air-
dried on bespoke drying racks for 3–4 hours and the dried blood
spots placed in low gas-permeable zip-closure plastic bags with
desiccant packages. [36] These were stored initially in –20uC
freezers at the 31 polyclinics, prior to transfer in cool boxes packed
with freezer packs to 280uC freezers at the central laboratory in
Minsk. The samples were stored at 220uC for a median of 1.6
months (IQR 1.0–5.0 months) and at 280uC for a median of 16.9
(IQR 12.6–20.2) months.
Training in Blood Spot Sampling
Paediatricians received training at a 1-day workshop and were
provided with a written manual of procedures and an illustrative
DVD. [35,39] Training included: the importance of proper
technique for ensuring adequate blood flow (warm fingers, held
below lap); emphasizing the need to allow blood to well on the
finger-tip (rather than apply excessive pressure) to minimize
haemolysis or dilution of the sample by interstitial fluid; and the
Figure 6. Stability of internal quality bloodspot samples stored at 280uC for 31 months. Fasting insulin concentrations of internal quality
control (IQC) bloodspots analysed at regular intervals over 31 months. For the ‘low’ IQC sample, the middle blue line is the mean insulin
concentration and the upper and lower blue lines are the 95% reference range (calculated from the standard deviation of 40 replicates); the
respective lines for the ‘high’ IQC sample are coloured green.
doi:10.1371/journal.pone.0046752.g006
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dropping them once onto the pre-printed filter circles (with no
blotting or re-spotting) to ensure adequate and evenly distributed
sample volume. Training was conducted by a consultant
biochemist (Dr Gusina) with extensive experience of running a
national neonatal screening programme based on filter-paper
blood spot collections. Feedback on the quality of spots was
provided to the paediatricians at workshops every 6-months during
the study fieldwork period. As blood spot cards arrived at the
central laboratory in Minsk, laboratory staff assessed and recorded
the quantity and quality of blood spots. Any paediatrician noted to
have consistent problems (e.g. blotting, spotting, fewer than 6 good
spots on average) was contacted by Dr Gusina to discuss
techniques to improve the quality of the blood spot collection.
Ethics
The study received ethical approval from McGill University
Health Centre Research Ethics Board; the Human Subjects
Committees at Harvard Pilgrim Health Care; and the Avon
Longitudinal Study of Parents and Children Law and Ethics
Committee. The conduct of the study was also approved by the
Ministry of Health of the Republic of Belarus. A parent or legal
guardian provided written informed consent and all children
provided written assent. The trial registration number for Current
Controlled Trials is ISRCTN37687716.
Statistical Analysis
Calibration curves were constructed with Multicalc software
(Wallac, Turku, Finland), using the log scale for both x and y axes.
To assess the relationship between insulin values from serum
versus blood spot samples collected simultaneously, we computed
the intraclass correlation coefficient (95% confidence interval)
using one-way analysis of variance and constructed a Bland-
Altman plot of the difference between the serum and bloodspot
insulin values (y-axis) against the mean of these two values (x-axis).
Linear regression accounting for clustering by polyclinic was used
to investigate relationships of fasting insulin levels with storage
time in the 280uC freezer, age, location of polyclinic (urban/
rural; East/West Belarus), puberty as measured by Tanner stage,
measures of general (BMI, fat mass), peripheral (triceps skinfold
thickness) and central (subscapular skinfold thickness, waist
circumference) adiposity, height, birthweight and fasting glucose.
We calculated sex-specific associations and performed a likelihood
ratio test for interactions between sex and the demographic,
glucose and anthropometric factors on insulin. Insulin concentra-
tions were log-transformed (ln(x)) for the analyses and geometric
means and log standard deviations are presented. Insulin values
below the lowest standard (1 mU/L, n=1,458) were assigned the
observed value (mean=0.5 mU/L, IQR=0.3–0.7), after deter-
mining amongst a sample of 80 children that repeating the assay
for these low values made no material difference to the observed
values. A sensitivity analysis excluding those 1,458 children with
an insulin concentration below 1 mU/L did not alter the observed
Figure 7. Fasting insulin concentrations by number of freeze-thaw cycles.
doi:10.1371/journal.pone.0046752.g007
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analyses were undertaken using Stata version 11 (StataCorp LP,
Texas).
Results
A typical calibration curve is shown in Figure 1. The precision
of the dried blood spot extraction and consecutive determination
by ELISA is summarised in Table 1. Mean intra-assay (n=157)
coefficients of variation were 15% and 6% for ‘low’ (6.7 mU/L)
and ‘high’ (23.1 mU/L) values, respectively; the respective inter-
assay values (n=33) were 23% and 11%.
Figure 2 shows a comparison of insulin values for 16 dried
blood spot samples stored at 280uC for 8 weeks versus insulin
concentrations measured in dried blood spots prior to frozen
storage (mean: 9.1 mU/L; range: 1.7 mU/L to 23.2 mU/L).
These data show a very strong correlation between insulin levels
measured before (fresh sample), compared to those measured after,
freezing (intraclass correlation coefficient=0.99; 95% confidence
interval, CI: 0.99 to 1.00). The mean difference between values
obtained from fresh versus frozen samples was very small and the
95% confidence interval was consistent with no true difference
(0.2 mU/L; 95% CI: 0.0 to 0.5). A Bland-Altman plot suggested
that low values of insulin were slightly increased, and high values
slightly reduced, after 8 weeks frozen storage (Figure 3).
However, the differences were small and the 95% limits of
agreement were within 1 mU/L. When three separate samples
were stored at +30uC, the values at 1 hour, 24 hours, 48 hours and
1 week were between 89% and 127% of the values at time 0
(Figure 4).
The results of the longer-term stability study at 280uC are
shown in Figures 5 and 6. Most values were within the 95%
reference range established from 30 replicates of the time 0 value.
In linear regression analyses, there was no evidence of any
association between storage time at 280uC and levels of insulin for
sample 1 (percentage change in insulin levels per
month=20.17%; 95% CI: 21.15 to 0.80; p=0.72), sample 2
(0.12%; 95% CI: 20.62 to 0.87; p=0.74), and the low (20.35%;
95% CI: 21.42 to 0.73; p=0.51) and high (0.09%; 95% CI:
20.71 to 0.89; p=0.81) internal quality control samples. There
were month-by-month fluctuations in line with the inter-assay
imprecision of measurements and in sample 3, the 18, 19 and 22
month readings were lower than expected. Overall sample 3 was
stable over 26 months, however, with a mean change in insulin
levels per month of 22.19%; (95% CI: 24.79 to 0.41; p=0.10).
Figure 7 shows that insulin concentrations for 3 samples
remained stable to being subjected to 4 freeze-thaw cycles.
Comparison of Samples
Comparison of 50 paired fasted whole bloodspots and serum
samples collected simultaneously gave an intraclass correlation
coefficient of 0.90 (95% confidence interval: 0.85 to 0.95)
(Figure 8), the range of serum values being 3.2 to 39.1 mU/L.
The Bland Altman plot shows that the 95% limits of agreement
were between 25.5 to +6.2 mU/L with a mean difference across
the range of values of 0.39 mU/L (CI 20.45 to 1.22) and no
evidence of a difference in variance across mean values (p=0.41)
(Figure 9).
Figure 8. Comparison of fasting insulin measured from 50 paired serum and whole bloodspot samples.
doi:10.1371/journal.pone.0046752.g008
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Variables
Out of a total of 13,879 children who were approached, a
total of 13,487 (97.2%) provided at least one and 13,403(96.6%)
provided at least two acceptable dried blood spot samples (two
were sufficient for the insulin assay). Amongst the 13,487
children, the paediatricians collected a median of 8 blood spots,
with 84.1% (11,347) of children assessed by the central
laboratory in Minsk as having had 8 acceptable quality blood
spots collected. We assayed a total of 12,812 children who
fasted for at least 8 hours. Table 2 shows mean (log standard
deviation) insulin levels in boys and girls by the following
variables: age-group; location of the polyclinic (urban/rural and
East/West); Tanner stage; BMI (normal weight, overweight and
obese as defined by the International Obesity Task Force,
IOTF BMI cut-offs [40]); waist circumference, fat mass, triceps
and subscapular thicknesses (above or below the 90th centile);
and quartiles of fasting glucose, height and birthweight. In both
boys and girls, mean insulin levels increased with Tanner stage
by pubic hair; all measures of adiposity (BMI, waist circumfer-
ence, fat mass and skinfold thicknesses); concurrent glucose
levels; and height. In girls, insulin levels were also positively
related to Tanner stage by breast development.
Discussion
The advantages of fingerstick blood collection onto filter paper
include ease of processing, storage and transport, thus providing a
valuable research tool for large epidemiology studies, particularly
those that are geographically dispersed. We have shown that
insulin in dried blood spots is stable and can be reliably quantified
on a very large-scale with modest infrastructure, making the
method useful for population-based studies of insulin resistance,
diabetes and cardiovascular risk in a variety of settings.
The dried blood spot methods showed acceptable analytical
performance characteristics and good agreement with the
conventional serum insulin assay across the distribution of insulin
values. There are several sources of variation unique to bloodspot
sampling and the assay that could explain differences between
bloodspot versus serum. For example, proper placement of the
whole blood sample on the filter paper is critical and errors can be
introduced if blood is blotted or smeared rather than drawn onto
the filter paper by capillary action. [32] We minimised this source
of error by rigorous training and regular feedback. Pre-printed
circles on the filter paper were used to help guide the
paediatricians to position the bloodspot. To maximise stability,
samples were placed in zip-closure bags packed with dessicant and
frozen at 220uC promptly after drying to reduce the chances of
degradation, although our stability study suggested insulin was
stable in dried blood spots when exposed to +30uC for one week.
These sources of variation are not seen with venepuncture
Figure 9. Bland-Altman plot for fasted bloodspot versus serum insulin assay in 50 paired samples.
doi:10.1371/journal.pone.0046752.g009
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characteristics, N=12,812.
Geometric mean (log SD) insulin levels (mU/L) and age-adjusted difference or change in
insulin (95% CI) per unit of demographic/clinical variable
N Girls N Boys p for sex interaction
Age group (yrs)
10–,11 385 3.1 (1.0) 393 2.3 (1.1)
11–,12 4851 4.2 (1.0) 4955 3.1 (1.1)
12–,13 962 3.8 (1.1) 1049 2.9 (1.2)
13–,14 100 1.7 (1.6) 117 2.3 (1.5) 0.01
Location
Rural 2654 4.0(1.0) 2694 2.9(1.1)
Urban 3644 4.0(1.0) 3820 3.0(1.1)
Difference in insulin
a 6298 1% (219%, 26%) 6514 3% (218%, 29%) 0.37
East 3022 4.1(1.0) 3004 3.0(1.1)
West 3276 3.9(1.1) 3510 2.9(1.1)
Difference in insulin
a 6298 23% (223%, 22%) 6514 23% (223%, 22%) 0.87
Tanner stage by breast (girls)/genitalia (boys)
I 705 2.7(1.0) 872 2.9(1.0)
II 3241 3.8(1.0) 3515 2.9(1.1)
III 2029 4.7(1.0) 1881 3.1(1.2)
IV/V 318 5.4(1.0) 238 3.4(1.3)
Change in insulin per category
a 6293 30% (21%, 39%) 6506 4% (27%, 16%) ,0.001
Tanner stage by pubic hair assessment
I 1751 3.2(1.0) 3248 2.8(1.1)
II 2962 4.1(1.0) 2684 3.1(1.1)
III 1402 4.9(1.0) 525 3.7(1.2)
IV/V 178 6.0(1.0) 49 4.5(1.0)
Change in insulin per category
a 6293 28% (19%, 37%) 6506 15% (5%, 26%) 0.01
Body mass index (kg/m
2)
b
Normal weight 5432 3.7(1.0) 5454 2.7(1.1)
Overweight 734 6.6(0.9) 819 4.5(1.0)
Obese 108 9.3(0.8) 213 6.5(0.8)
Change in insulin per category
a 6274 70% (58%, 84%) 6486 60% (51%, 69%) 0.93
Waist circumference (cm)
,90
th centile 5689 3.7(1.0) 5811 2.7(1.1)
$90
th centile 595 7.7(0.8) 679 5.6(1.0)
Difference in insulin
a 6284 108% (87%, 130%) 6490 105% (84%, 128%) 0.68
Fat mass (kg)
,90
th centile 5410 3.7(1.0) 6005 2.8(1.1)
$90
th centile 798 6.7(1.0) 449 6.2(0.9)
Difference in insulin
a 6208 83% (64%, 105%) 6454 121% (91%, 157%) 0.03
Triceps thickness (mm)
,90
th centile 5658 3.8(1.0) 5963 2.8(1.1)
$90
th centile 628 6.8(0.9) 533 5.4(1.0)
Difference in insulin
a 6286 82% (56%, 112%) 6496 93% (70%, 119%) 0.85
Subscapular thickness (mm)
,90
th centile 5621 3.7(1.0) 5926 2.8(1.1)
$90
th centile 627 6.9(0.9) 532 5.3(1.0)
Difference in insulin
a 6248 84% (65%, 105%) 6458 91% (74%, 110%) 0.68
Height (cm)
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not adjusted for in each sample; any sample differences would
introduce errors. The exact reason why there were outliers outside
the 95% limits of agreement in Figure 9 is not clear, but may be
related to the quality of the blood spots or haematocrit variation.
The variation seen in Figures 5 and 6 is broadly in line with the
imprecision suggested in Table 1, although in Figure 6, the CV
for the high IQC samples used in the stability study was slightly
higher at 18%, which could reflect sources of variation outlined
above. Despite unique sources of error, we achieved a good
correlation between dried blood spot versus serum methods of
measurement. In addition, although bloodspot assays are inher-
ently less precise than serum assays, the present ELISA method
exhibited intra- and inter-assay coefficients of variation (see
Table 1) that compare favourably with those reported for
radioimmunoassay (14.0% and 25.0%, respectively) [32] and
chemiluminescence (11.7–29.8% and 9.8–15.5%, respectively,
from Table 3 of reference [33]) methods for insulin quantification
in dried blood spots.
This is the first study we are aware of to report the long-term
stability of insulin in dried blood spots, and our data show stability
for over 2 years when frozen at 280uC. Reassuringly, we have
shown that samples can be left at very high room temperatures for
up to a week (+30uC) and remain stable, providing some flexibility
when samples are being collected in the field (e.g. in remote sites
with limited immediate access to freezers).
A range of 1–50 mU/L was selected for the assay to cover the
anticipated whole blood insulin concentrations of children. Our
lower limit of detection (1 mU/L) and high intraclass correlation
(0.90) between serum and dried blood spot measurements,
collected simultaneously, compares favourably with the chemilu-
minescent immunoassay assay developed by Butter et al (lower
limit of detection=0.8 mU/L; correlation=0.89 between paired
whole bloodspots and serum samples). [33] The close agreement
between dried blood spot (measured against bloodspot standards)
and conventional serum (measured against liquid buffer standards)
assays strongly supports the validity of dried bloodspot insulin
analysis. We have also demonstrated that insulin is stable when
exposed to at least four freeze-thaw cycles, indicating that samples
can be reanalysed without loss of insulin.
Red blood cells contain an insulin degrading enzyme that
cleaves insulin. We did not investigate the effect of adding an
insulin degrading enzyme inhibitor to the eluate, because Butter et
al showed that this did not improve insulin concentrations
measured from whole bloodspots, [33] speculating that since the
action of applying whole blood to filter paper causes red blood
cells to lyse, this may release insulin degrading enzymes before
assay incubation.
In our fieldwork study, we showed that taking capillary blood
samples from children is feasible on a large scale, since only 3%
(n=392) of 13,879 children approached did not provide a useable
sample and the paediatricians were able to take a median of 8
acceptable blood spots amongst those who were sampled.
Although we documented slightly greater imprecision than would
be expected in serum samples, the mean values in girls and boys
that we observed, and our analysis of established associations of
insulin levels with adiposity measures, puberty, glucose and height,
were in line with previously published results. [41].
The advantages of filter paper capillary blood sampling,
combined with the acceptable analytical performance character-
istics of the dried blood spot assays, makes the approach ideal for
large-scale epidemiologic applications, including studies of chil-
Table 2. Cont.
Geometric mean (log SD) insulin levels (mU/L) and age-adjusted difference or change in
insulin (95% CI) per unit of demographic/clinical variable
N Girls N Boys p for sex interaction
Q1 1412 2.9(1.0) 1793 2.3(1.1)
Q2 1628 3.7(1.0) 2006 3.0(1.1)
Q3 1490 4.4(1.0) 1448 3.2(1.1)
Q4 1766 5.1(1.0) 1263 4.0(1.1)
Change in insulin per 10 cm
a 6296 36% (30%, 43%) 6510 33% (25%, 42%) 0.80
Birthweight (g)
Q1 1974 4.0(1.0) 1369 2.9(1.2)
Q2 1660 4.0(1.1) 1430 3.0(1.1)
Q3 1485 3.9(1.1) 1796 3.0(1.1)
Q4 1179 4.1(1.0) 1916 3.0(1.1)
Change in insulin per 100g
a 6298 0% (21%, 1%) 6511 0% (21%, 1%) 0.55
Glucose(mmol/l)
Q1 2069 3.4(1.1) 2053 2.4(1.2)
Q2 1246 4.0(1.0) 1307 3.0(1.0)
Q3 1449 4.5(1.0) 1526 3.3(1.1)
Q4 1525 4.5(1.0) 1623 3.5(1.1)
Change in insulin per SD increase in
glucose
a
6289 12% (5%, 18%) 6509 19% (12%, 25%) 0.19
SD=standard deviation; CI=confidence interval.
aLinear regression coefficient and 95% CI (age-adjusted).
bNormal weight, overweight and obese as defined by the International Obesity Task Force, IOTF BMI cut-offs. [40].
doi:10.1371/journal.pone.0046752.t002
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sample collection and transportation to distant laboratories may be
limiting factors. There are caveats, as previously pointed out,
including the need for adequate training for those taking the
bloodspot samples onto filter paper, to avoid several sources of
error, and the fact that we have developed the dried bloodspot
assay for research and not clinical use, which would require
additional investigation. [42].
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